» Articles » PMID: 31190355

MiR-22 Enhances the Radiosensitivity of Small-cell Lung Cancer by Targeting the WRNIP1

Overview
Journal J Cell Biochem
Date 2019 Jun 14
PMID 31190355
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Small-cell lung cancer (SCLC) is an aggressive malignancy characterized by high cellular proliferation and early distant metastasis. Our study aimed to explore the effect of miR-22-3p (miR-22, for short) on SCLC radiosensitivity and its molecular mechanisms. The expression level of miR-22 was evaluated in a human normal lung epithelial cell line and a human SCLC cell line, and cell apoptosis and migration were detected. The expression of the miR-22 direct target WRNIP1 mRNA and protein were explored. Five differentially expressed genes were detected. The miR-22 expression in NCI-H446 was significantly decreased, and miR-22 overexpression significantly promoted cell apoptosis. miR-22 overexpression could significantly inhibit the cell migration of SCLC cells, and miR-22 had a negative regulatory effect on WRNIP1 mRNA and protein levels. KLK8 was downregulated, and the messenger RNA (mRNA) of four other genes (PC, SCUBE1, STC1, and GPM6A) was upregulated mRNA in cells overexpressing miR-22, which was in accordance with the bioinformatics analysis. miR-22 could enhance the radiosensitivity of SCLC by targeting WRNIP1.

Citing Articles

Mechanisms of GPM6A in Malignant Tumors.

Huang B, Li X Cancer Rep (Hoboken). 2025; 8(2):e70137.

PMID: 39957375 PMC: 11831008. DOI: 10.1002/cnr2.70137.


Targeting STK26 and ATG4B: miR-22-3p as a modulator of autophagy and tumor progression in HCC.

Li K, Bai Y, Wang J, Ren L, Mo A, Liu R Transl Oncol. 2024; 51:102214.

PMID: 39608212 PMC: 11635773. DOI: 10.1016/j.tranon.2024.102214.


Research Trends and Evolution in Radiogenomics (2005-2023): Bibliometric Analysis.

Wang M, Peng Y, Wang Y, Luo D Interact J Med Res. 2024; 13:e51347.

PMID: 38980713 PMC: 11267093. DOI: 10.2196/51347.


An innovative prognostic auxiliary for colon adenocarcinoma based on zinc finger protein genes.

Xu F, Sun J, Gu X, Zhou Q Transl Cancer Res. 2024; 13(4):1623-1641.

PMID: 38737696 PMC: 11082816. DOI: 10.21037/tcr-23-2158.


Evaluating CD133 as a Radiotheranostic Target in Small-Cell Lung Cancer.

Sarrett S, Rodriguez C, Delaney S, Hosny M, Sebastiano J, Santos-Coquillat A Mol Pharm. 2024; 21(3):1402-1413.

PMID: 38331430 PMC: 10915790. DOI: 10.1021/acs.molpharmaceut.3c01063.


References
1.
Zhou J, Liu J, Cheng C, Patel T, Weller C, Piepmeier J . Biodegradable poly(amine-co-ester) terpolymers for targeted gene delivery. Nat Mater. 2011; 11(1):82-90. PMC: 4180913. DOI: 10.1038/nmat3187. View

2.
Chun-Zhi Z, Lei H, An-Ling Z, Yan-Chao F, Xiao Y, Guang-Xiu W . MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer. 2010; 10:367. PMC: 2914702. DOI: 10.1186/1471-2407-10-367. View

3.
Johnson S, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A . RAS is regulated by the let-7 microRNA family. Cell. 2005; 120(5):635-47. DOI: 10.1016/j.cell.2005.01.014. View

4.
Kasinski A, Slack F . Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011; 11(12):849-64. PMC: 4314215. DOI: 10.1038/nrc3166. View

5.
Babar I, Cheng C, Booth C, Liang X, Weidhaas J, Saltzman W . Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma. Proc Natl Acad Sci U S A. 2012; 109(26):E1695-704. PMC: 3387084. DOI: 10.1073/pnas.1201516109. View